Chronic pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects volunteered and signed the informed consent form for the trial; (2) Patients with chronic pain have a history of more than 1 month; VAS is greater than 40mm (3) The patient/legal guardian must be able to read, understand and sign the informed consent form (ICF); (4) Have the ability to understand and complete various scales; (5) Subjects can follow the drug dose and visit plan and cooperate with follow-up, including mobile phone APP follow-up; (6) Patients with contraindications of non-acetylaconitine drugs; (7) No drug abuse or drug addiction; (8) Non-feeding and pregnant women: subjects (including male subjects) without pregnancy plan within 1 month after the trial.
Exclusion criteria
Exclusion criteria: (1) the patient was or is currently participating in or planning to participate in any interventional clinical study 3 months ago; (2) the researcher considered that the patients were not fit to participate in this study; (3) the sponsor or researcher directly involved in the trial or their family members. (4) other aconitines have been taken orally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scale, VAS;ID pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Numeric Pain Rating Scale;Douleur Neuropathique 4 questions,(DN4);Leeds Assessment of Neuropathic Symptoms and Signs, LANSS;Simplified McGill Pain Questionnaire;Pittsburgh Sleep Quality Index;The Patient Health Questionnaire(PHQ-9);Generalized Anxiety Disorder-7(GAD-7); | — |
Countries
China
Contacts
Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine